More on CTMX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.96 |
|
|||
| Open | $3.02 | ||||
| 52 Wk High | $24.68 | ||||
| 52 Wk Low | $9.10 | ||||
| Day High | $3.07 | ||||
| Day Low | $2.89 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 9,732,498 | ||||
- Form 4 CytomX Therapeutics, For: Jun 15 Filed by: Ogden Christopher
- Form 8-K CytomX Therapeutics, For: May 29
- CytomX expands Regeneron collaboration, receives $37 million payment
- CytomX Announces Expansion of Strategic Research Collaboration with Regeneron in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer
- CytomX Therapeutics to Present at Upcoming June Investor Conferences
- Wolfe Research Starts CytomX Therapeutics (CTMX) at Outperform
- CytomX hires Mamata Gokhale as regulatory affairs head
- CytomX Therapeutics Appoints Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs
- Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Seven Fleet Capital Management LP
- Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: Longitude Capital Partners V, LLC
Entities mentioned with CTMX
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- Show More...
